MCRB - Seres Therapeutics soars on report of takeover offer
2025-09-08 09:04:34 ET
More on Seres Therapeutics
- Seres Therapeutics, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript
- Seres?Therapeutics: Speculative Gem Backed By SER?155 FDA Breakthrough
- Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks
- Seres Therapeutics GAAP EPS of -$2.27 beats by $0.22